All of Us研究项目中弱视的全基因组与罕见变异关联研究
该病例对照研究利用All of Us研究项目中764例弱视患者和122305例无弱视记录的对照(仅纳入欧洲遗传祖先参与者),进行常见变异GWAS和基因水平罕见变异关联研究。GWAS发现4个接近统计学显著性的位点,RVAS发现15个基因变异负荷有统计学差异,部分基因已知参与神经发育。结论提示弱视的神经发育改变可能不仅是异常视觉体验的继发结果,还可能与原发性神经发育缺陷的交互作用有关。
要点
- GWAS发现4个接近统计学显著性(P<5e-8)的位点:rs56105618、rs1349660、rs7958343和rs138693522。
- RVAS发现15个基因罕见变异负荷有统计学差异(P<5e-05),包括DCP1B、OR12D2、PCDHA4等,部分与神经发育相关。
- 作者认为弱视的神经发育改变可能源于原发性神经发育缺陷与异常视觉体验的交互作用,或可解释相同眼部危险因素下弱视发生的差异及治疗结局差异。
核心结论
- 与弱视相关的基因在神经发育中起作用,提示弱视的神经发育改变不仅是异常视觉体验的继发结果,还可能是原发性神经发育缺陷与异常体验交互作用所致。
- 这可能解释为何相同眼部危险因素下有些儿童发生弱视而另一些不发生,也可能解释治疗结局的差异,并为弱视治疗提示新途径。
研究设计与样本
- 病例对照研究,比较764例弱视患者(基于国际疾病分类和医学系统命名法编码)与122305例无弱视记录且具有全基因组测序数据的对照。
- 仅纳入欧洲遗传祖先参与者,因其他祖先群体中受累参与者数量少。
- 对常见变异(次要等位基因频率>1%)进行全基因组关联研究(GWAS),并对弱视进行基因水平的罕见变异关联研究(RVAS)。
主要发现
- GWAS revealed 4 loci that approached statistical significance defined as P < 5e-8: rs56105618, rs1349660, rs7958343, and rs138693522.
- 每个变异均为在大脑表达或与神经发育相关基因的表达数量性状位点(eQTL)。
- RVAS发现15个基因变异负荷有统计学差异(P<5e-05):DCP1B、OR12D2、PCDHA4、ALKBH8、NMUR2、OR52P1P、NEU1、CACNB2、PSMA7、LRR1、ZNF831、FSIP2、ZNF654、CES5A和MPV17,其中若干基因已知在神经发育中起作用。
局限性
- 仅纳入欧洲遗传祖先参与者,因其他祖先群体中受累参与者数量少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Amblyopia is characterized by decreased visual acuity due to abnormal visual experience during development. It affects approximately 3% of the population and is associated with abnormal development of the visual cortex. Despite treatment, many patients have residual visual acuity deficits. This study aimed to explore the genetic contributions to amblyopia. DESIGN: Case-control. PARTICIPANTS: The All of Us Research Program includes genotypic and phenotypic data from a diverse population of adults (age ≥ 18 years) across the United States. A total of 764 subjects with amblyopia (based on International Classification of Diseases and Systematized Nomenclature of Medicine codes) and 122 305 controls with no record of amblyopia and with whole genome sequencing data were compared. Only participants of European genetic ancestry were included because of small numbers of affected participants in other ancestral groups. METHODS: Genome-wide association study (GWAS) of common variants (minor allele frequency > 1%) and rare variant association study (RVAS) at the gene level for amblyopia of participants in the All of Us Research Program. MAIN OUTCOME MEASURES: Individual single nucleotide polymorphisms (SNPs) significantly associated with amblyopia and genes with significant burden of rare variants in amblyopia. RESULTS: The GWAS revealed 4 loci that approached statistical significance defined as P < 5e-8: rs56105618, rs1349660, rs7958343, and rs138693522. Each of the variants is an expression quantitative trait locus (eQTL) for a gene expressed in the brain or related to neural development. This RVAS revealed 15 genes with a statistically significant (P < 5e-05) different burden of variants: DCP1B, OR12D2, PCDHA4, ALKBH8, NMUR2, OR52P1P, NEU1, CACNB2, PSMA7, LRR1, ZNF831, FSIP2, ZNF654, CES5A, and MPV17, several of which have known roles in neurodevelopment. CONCLUSIONS: The identification of genes linked to amblyopia with roles in neurodevelopment suggests that the neurodevelopmental changes in amblyopia are not only secondary to abnormal visual experience but also may result from the interaction of primary neurodevelopmental deficits with abnormal experience. This potentially explains why some children develop amblyopia and others do not with the same ocular risk factors, may explain differences in treatment outcomes, and suggests new avenues for amblyopia treatment. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.
引用
- Lee KAV, Aboobakar IF, Jain A, et al. Genome-Wide and Rare Variant Association Studies of Amblyopia in the All of Us Research Program. Ophthalmology. 2025. PMID: 39842729. doi:10.1016/j.ophtha.2025.01.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。